Skip to main navigation

BioAtla, Inc logo

preloader
BioAtla, Inc logo
  • Overview
  • News & Events
    • News Releases
    • Events and Presentations
  • Governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Stock
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Events and Presentations

Presentations

Corporate Presentation – November 2024 2.7 MB
2024 Annual Shareholder Meeting 25.5 MB

Past Events

5/11/23 at 4:30 PM EDT
BioAtla First Quarter 2023 Financial Results and Business Highlights Conference Call
Click here for webcast
3/23/23 at 4:30 PM EDT
BioAtla Fourth Quarter and Full-Year 2022 Financial Results and Business Highlights Conference Call
Click here for webcast
1/10/23 at 3:00 PM PST
41st Annual J.P. Morgan Healthcare
Click here for webcast
6/8/22 at 10:00 AM EDT
Jefferies Global Healthcare Conference
Click here for webcast

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
logo-footer

BioAtla® is a leading San Diego-based biopharmaceutical company developing safer and more effective drugs for cancer. Its Conditionally Active Biologics™ (CAB) platform exploits the unique microenvironment of diseased tissue to more effectively target cancer.

BIOATLA®

  • Technology
  • CAB Portfolio
  • Appendix

COMPANY

  • About
  • Team
  • Careers
  • News

LEGAL

  • Privacy Policy
  • Site Map
  • Expanded Access

GET IN TOUCH

  • Contact
  • Corporate Headquarters +1 858-558-0708

FOLLOW US

  • LinkedIn
  • Copyright © 2025 BioAtla®, Inc. All rights reserved